ATE329910T1 - 5-trityloxymethyl-2-oxazolidinon und verfahren zu dessen herstellung - Google Patents

5-trityloxymethyl-2-oxazolidinon und verfahren zu dessen herstellung

Info

Publication number
ATE329910T1
ATE329910T1 AT01953494T AT01953494T ATE329910T1 AT E329910 T1 ATE329910 T1 AT E329910T1 AT 01953494 T AT01953494 T AT 01953494T AT 01953494 T AT01953494 T AT 01953494T AT E329910 T1 ATE329910 T1 AT E329910T1
Authority
AT
Austria
Prior art keywords
trityloxymethyl
oxazolidinone
production
trityloxy
oxazolidinones
Prior art date
Application number
AT01953494T
Other languages
English (en)
Inventor
Rawle I Hollingsworth
Guijun Wang
Original Assignee
Univ Michigan State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Michigan State filed Critical Univ Michigan State
Application granted granted Critical
Publication of ATE329910T1 publication Critical patent/ATE329910T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05—Isotopically modified compounds, e.g. labelled

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT01953494T 2000-09-19 2001-07-16 5-trityloxymethyl-2-oxazolidinon und verfahren zu dessen herstellung ATE329910T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/665,508 US6288239B1 (en) 2000-09-19 2000-09-19 5-trityloxymethyl-oxazolidinones and process for the preparation thereof

Publications (1)

Publication Number Publication Date
ATE329910T1 true ATE329910T1 (de) 2006-07-15

Family

ID=24670388

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01953494T ATE329910T1 (de) 2000-09-19 2001-07-16 5-trityloxymethyl-2-oxazolidinon und verfahren zu dessen herstellung

Country Status (10)

Country Link
US (1) US6288239B1 (de)
EP (1) EP1324989B1 (de)
JP (1) JP3974035B2 (de)
KR (1) KR100525882B1 (de)
AT (1) ATE329910T1 (de)
AU (2) AU2001275937B2 (de)
CA (1) CA2418200C (de)
DE (1) DE60120729D1 (de)
TW (1) TWI237637B (de)
WO (1) WO2002024670A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU230030B1 (hu) 1999-10-08 2015-05-28 Debiopharm International Sa Fab I inhibitorok
EP1560584B1 (de) * 2001-04-06 2009-01-14 Affinium Pharmaceuticals, Inc. Fab-i-inhibitoren
WO2003106413A2 (en) * 2001-10-18 2003-12-24 Michigan State University Process for the preparation of oxazolidinones and method of use thereof
EP1575951B1 (de) * 2002-12-06 2014-06-25 Debiopharm International SA Heterozyclische verbindungen, verfahren zu deren herstellung und ihre verwendung als heilmittel
WO2004082586A2 (en) * 2003-03-17 2004-09-30 Affinium Pharmaceuticals, Inc. Phamaceutical compositions comprising inhibitors of fab i and further antibiotics
DK1828167T3 (da) * 2004-06-04 2014-10-20 Debiopharm Int Sa Acrylamidderivater som antibiotiske midler
KR20080075027A (ko) * 2005-12-05 2008-08-13 아피늄 파마슈티컬스, 인크. Ｆａｂｉ 억제제 및 항박테리아제로서의헤테로시클릴아크릴아미드 화합물
JP5468899B2 (ja) 2006-07-20 2014-04-09 アフィニウム ファーマシューティカルズ， インク． Ｆａｂｉインヒビターとしてのアクリルアミド誘導体
EP2125802A4 (de) 2007-02-16 2014-08-20 Debiopharm Int Sa Salze, prodrugs und polymorphe von fab-i-inhibitoren
KR200453944Y1 (ko) * 2011-03-08 2011-06-03 조명호 음식물 배달용기
AU2013279021C1 (en) 2012-06-19 2017-03-16 Debiopharm International Sa Prodrug derivatives of (E)-N-methyl-N-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide
RS61312B1 (sr) 2016-02-26 2021-02-26 Debiopharm Int Sa Lek za lečenje infekcija dijabetskog stopala
TN2021000159A1 (en) 2019-02-14 2023-04-04 Debiopharm Int Sa Afabicin formulation, method for making the same and uses thereof
SG11202113174SA (en) 2019-06-14 2021-12-30 Debiopharm Int Sa Medicament and use thereof for treating bacterial infections involving biofilm

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5122601A (en) * 1990-12-07 1992-06-16 Hawaiian Sugar Planters'association Synthesis of 2,3,3',4,4'-penta-o-methylsucrose
CA2049536C (en) 1991-05-13 1999-07-06 Rawle I. Hollingsworth Process for the preparation of 3,4-dihydroxybutanoic acid and salts thereof
DK1114819T3 (da) 1996-04-11 2008-04-14 Pharmacia & Upjohn Co Llc Fremgangsmåde til fremstilling af oxazolidinoner
US5808107A (en) 1997-10-31 1998-09-15 Board Of Trustees Operating Michigan State University Process for the preparation of hydroxy substituted gamma butyrolactones
IT1301977B1 (it) * 1998-07-31 2000-07-20 Sigma Tau Ind Farmaceuti Procedimento per la preparazione di r-(-)-carnitina

Also Published As

Publication number Publication date
AU7593701A (en) 2002-04-02
KR20030025301A (ko) 2003-03-28
EP1324989A1 (de) 2003-07-09
CA2418200C (en) 2006-07-04
KR100525882B1 (ko) 2005-11-02
EP1324989B1 (de) 2006-06-14
TWI237637B (en) 2005-08-11
JP3974035B2 (ja) 2007-09-12
AU2001275937B2 (en) 2005-08-11
DE60120729D1 (de) 2006-07-27
WO2002024670A1 (en) 2002-03-28
JP2004523473A (ja) 2004-08-05
CA2418200A1 (en) 2002-03-28
US6288239B1 (en) 2001-09-11
EP1324989A4 (de) 2005-07-20

Similar Documents

Publication Publication Date Title
DE60120729D1 (de) 5-trityloxymethyl-2-oxazolidinon und verfahren zu dessen herstellung
DE69818674D1 (de) Kristallmodifikation eines h-phenyl-2-pyrimidinamin-derivates, verfahren zu deren herstellung und deren anwendung
DE69627709D1 (de) N-(unsubstituierte oder substituierte)-4-substituierte-6-(unsubstituierte oder substituierte)phenoxy-2-pyridincarboxamide oder -thiocarboxamide, verfahren zu deren herstellung sowie herbizide
ATE322269T1 (de) Aripiprazole wirkstoff mit niedriger hygroskopie und verfahren zu ihrer herstellung
ATE221531T1 (de) Kristallmodifikation des cdch, verfahren zu dessen herstellung und diese enthaltende pharmazeutische zubereitungen
DE69730737D1 (de) Optisch aktive nitroalkohol-derivate, optisch aktive aminoalkohol-derivate und verfahren zu ihrer herstellung
DE50213524D1 (de) Kationische sterolderivate, ph-sensitive liposomen diese umfassend und verfahren zur wirkstoffbeladung von liposomen
DE60004220D1 (de) Polymerisierte modifizierte teilchen und verfahren zu derren herstellung
ATE332898T1 (de) Neue dihydropteridinone, verfahren zu deren herstellung und deren verwendung als arzneimittel
DE50212077D1 (de) Piezoelektrisches bauelement und verfahren zu dessen herstellung
DE50004150D1 (de) Polymorphe von telmisartan, verfahren zu deren herstellung und deren verwendung zur herstellung eines arzneimittels
DE60037186D1 (de) Einfaches kulturmedium und verfahren zu dessen herstellung
DE60220807D1 (de) Dehnbare multikomponentenfaser-spinnvliese und verfahren zu deren herstellung
DE60037287D1 (de) Piezoelektrisches/elektrostriktives Bauelement und Verfahren zu seiner Herstellung
ATE304013T1 (de) 1,2,3-substituierte indolizinderivate, fgf inhibitoren, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
DE60226707D1 (de) Kunsthaare und verfahren zu deren herstellung
ATE442852T1 (de) Trimetazidine enthaltendes arzneimittel mit verzögerter wirkstoffabgabe und verfahren zur herstellung
DE59914950D1 (de) Feldeffektgesteuerter transistor und verfahren zu dessen herstellung
DE60033017D1 (de) Halbleiterlaser, verfahren zu dessen herstellung und optische plattenvorrichtung
DE60236790D1 (de) Piezoelektrischer oszillator und verfahren zu seiner herstellung
DE60229488D1 (de) Piezoelektrisches Bauelement und Verfahren zu dessen Herstellung
DE69818720D1 (de) Heteroübergangsfeldeffekttransistor und Verfahren zu dessen Herstellung
DE60100527D1 (de) Lederhänliches blattförmiges produkt und verfahren zu dessen herstellung
ATE301645T1 (de) Polycyclische thiazolidin-2-yliden amine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
ATE313524T1 (de) 1,1- and 1,2-disubstituierte cyclopropane, verfahren zu deren herstellung und deren pharmazeutischen zusammensetzungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties